Andersen, Dana K.Korc, MurrayPetersen, Gloria M.Eibl, GuidoLi, DonghuiRickels, Michael R.Chari, Suresh T.Abbruzzese, James L.2018-11-302018-11-302017-05Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., … Abbruzzese, J. L. (2017). Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes, 66(5), 1103-1110.https://hdl.handle.net/1805/17858The relationships between diabetes and pancreatic ductal adenocarcinoma (PDAC) are complex. Longstanding type 2 diabetes (T2DM) is a risk factor for pancreatic cancer, but increasing epidemiological data point to PDAC as also a cause of diabetes due to unknown mechanisms. New-onset diabetes is of particular interest to the oncology community as the differentiation of new-onset diabetes caused by PDAC as distinct from T2DM may allow for earlier diagnosis of PDAC. To address these relationships and raise awareness of the relationships between PDAC and diabetes, a symposium entitled Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer was held at the American Diabetes Association's 76th Scientific Sessions in June 2016. This article summarizes the data presented at that symposium, describing the current understanding of the interrelationships between diabetes, diabetes management, and pancreatic cancer, and identifies areas where additional research is needed.en-USPublisher PolicyBlood GlucoseCarcinoma, Pancreatic DuctalCausalityDiabetes MellitusGenetic Predisposition to DiseaseHypoglycemic AgentsPancreatic NeoplasmsArticle